# Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus

> **NCT00207311** · PHASE4 · COMPLETED · sponsor: **Brooke Army Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Fatty Liver
- Hepatitis C

## Interventions

- **DRUG:** Xenical, Pegasys, Copegus
- **BEHAVIORAL:** Xenicare Program

## Key facts

- **NCT ID:** NCT00207311
- **Lead sponsor:** Brooke Army Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-02-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00207311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00207311, "Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00207311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*